References

  1. Ågerup B, Berg P, Åkermark C. Non-animal stabilized hyaluronic acid: a new formulation for the treatment of osteoarthritis. BioDrugs. 2005;19(1):23-30. doi:10.2165/00063030-200519010-00003
  2. Leighton R, Åkermark C, Therrien R, et al. NASHA hyaluronic acid vs. methylprednisolone for knee osteoarthritis: a prospective, multi-centre, randomized, non-inferiority trial. Osteoarthritis Cartilage. 2014;22(1):17-25. doi:10.1016/j.joca.2013.10.009
  3. Arden NK, Åkermark C, Andersson M, Todman MG, Altman RD. A randomized saline-controlled trial of NASHA hyaluronic acid for knee osteoarthritis. Curr Med Res Opin. 2014;30(2):279-86. doi:10.1185/03007995.2013.855631
  4. McGrath AF, McGrath AM, Jessop ZM, et al. A comparison of intra-articular hyaluronic acid competitors in the treatment of mild to moderate knee osteoarthritis. J Arthritis. 2013;2(1):1000108. doi:10.4172/2167-7921.1000108
  5. Krocker D, Matziolis G, Tuischer J, et al. Reduction of arthrosis associated knee pain through a single intra-articular injection of synthetic hyaluronic acid. Z Rheumatol. 2006;65(4):327-31. doi:10.1007/s00393-006-0063-2
  6. Altman RD, Åkermark C, Beaulieu AD, Schnitzer T. Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis Cartilage. 2004;12(8):642-49. doi:10.1016/j.joca.2004.04.010
  7. Conrozier T, Couris CM, Mathieu P, et al. Safety, efficacy and predictive factors of efficacy of a single intra-articular injection of non-animal-stabilized-hyaluronic-acid in the hip joint: results of a standardized follow-up of patients treated for hip osteoarthritis in daily practice. Arch Orthop Trauma Surg. 2009;129(6):843-8. doi:10.1007/s00402-008-0778-4
  8. Berg P, Olsson U. Intra-articular injection of non-animal stabilised hyaluronic acid (NASHA) for osteoarthritis of the hip: a pilot study. Clin Exp Rheumatol. 2004;22(3):300-6
  9. Altman R, Lim S, Steen RG, Dasa V. Hyaluronic acid injections are associated with delay of total knee replacement surgery in patients with knee osteoarthritis: evidence from a large U.S. health claims database. PLoS One. 2015;10(12):e0145776. doi: 10.1371/journal.pone.0145776
  10. Romero Jurado M, Enrique Fidalgo A, Rodríguez Villar V, Mar Medina J, Soler López B. Factors related with the time to surgery in waiting-list patients for knee prostheses. Reumatol Clin. 2013;9(3):148-55. doi:10.1016/j.reumae.2013.03.005
  11. Kompel AJ, Roemer FW, Murakami AM, Diaz LE, Crema MD, Guermazi A. Intra-articular corticosteroid injections in the hip and knee: perhaps not as safe as we thought? Radiology. 2019;293(3):656-63. doi:10.1148/radiol.2019190341
  12. McAlindon TE, LaValley MP, Harvey WF, et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA. 2017;317(19):1967-75. doi:10.1001/jama.2017.5283
  13. Bioventus LLC. Quantity of DUROLANE Patients Treated. Data on file, RPT-001056.
  14. Osteoarthritis Research Society International. What is Osteoarthritis? https://www.oarsi.org/what-osteoarthritis. Accessed July 28, 2020.
  15. Arthritis Society. What is Arthritis. https://arthritis.ca/about-arthritis/what-is-arthritis. Accessed July 28, 2020.
  16. Arthritis Society. Osteoarthritis. Last updated September 2017. https://arthritis.ca/about-arthritis/arthritis-types-(a-z)/types/osteoarthritis 
  17. Arthritis Foundation. Osteoarthritis. https://www.arthritis.org/diseases/osteoarthritis.
  18. Canadian Orthopaedic Association. Arthroscopy Association of Canada. Position Statement on IntraArticular
    Injections for Knee Osteoarthritis. Last updated August 2020. https://coa-aco.org/wp-content/uploads/2020/08/AAC-Intra-articular-Injections-for-Knee-OA-Updated-August-2020.pdf
  19. Mayo Clinic. Exercise helps ease arthritis pain and stiffness. Posted December 19, 2018. www.mayoclinic.org/diseases-conditions/arthritis/in-depth/arthritis/art-20047971
  20. Health Canada. Health Canada Clarifies Position on Platelet Rich Plasma. Last updated August 26,2019. https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/70559a-eng.php
  21. Altman RD, Manjoo A, Fierlinger A, Niazi F, Nicholls M. The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskelet Disord. 2015;16:321. doi:10.1186/s12891-015-0775-z
  22. Altman RD, Fredericson M, Bhattacharyya SK, et al. Association between hyaluronic acid injections and time-to-total knee replacement surgery. J Knee Surg. 2016;29(7)564-70 doi:10.1055/s-0035-1568992
  23. Papakonstantinou E, Roth M, Karakiulakis G. Hyaluronic acid: a key molecule in skin aging. Dermatoendocrinol. 2012;4(3):253-58. doi:10.4161/derm.21923
  24. Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl. 1993;39:3-9.
  25. Ågerup B, Berg P, Åkermark C. Non-animal stabilized hyaluronic acid: a new formulation for the treatment of osteoarthritis. BioDrugs. 2005;19(1):23-30. doi:10.2165/00063030-200519010-00003
  26. Lindqvist U, Tolmachev V, Kairemo K, Aström G, Jonsson E, Lundqvist H. Elimination of stabilised hyaluronan from the knee joint in healthy men. Clin Pharmacokinet. 2002;41(8):603-13. doi:10.2165/00003088-200241080-00004
  27. Bioventus LLC. DUROLANE 2M Patients Treated. Bioventus data on file, RPT-001056.
  28. Zhang H, Zhang K, Zhang X, et al. Comparison of two hyaluronic acid formulations for safety and efficacy (CHASE) study in knee osteoarthritis: a multicenter, randomized, double-blind, 26-week non-inferiority trial comparing Durolane to Artz. Arthritis Res Ther. 2015;17(1):51. doi:10.1186/s13075-015-0557-x
  29. Edsman K, Hjelm R, Lärkner H, et al. Intra-articular duration of Durolane™ after single injection into the rabbit knee. Cartilage. doi:10.177/1947603511400184
  30. Bioventus LLC. Galderma: Molecular Weight of DUROLANE. Data on file, RPT-000834.
  31. Larsen NE, Dursema HD, Pollak CT, Skrabut EM. Clearance kinetics of a hylan-based viscosupplement after intra-articular and intravenous administration in animal models. J Biomed Mater Res B Appl Biomater. 2012;100(2):457–62. doi:10.1002/jbm.b.31971
  32. Brown TJ, Laurent UB, Fraser JR. Turnover of hyaluronan in synovial joints: elimination of labelled hyaluronan from the knee joint of the rabbit. Exp Physiol. 1991;76(1):125–34. do1:10.1113/expphysiol.1991.sp003474
  33. DUROLANE [package insert] Durham, NC: Bioventus LLC; 2019
  34. Wongrakpanich S, Wongrakpanich A, Melhado K, Rangaswami J. A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly. Aging Dis. 2018;9(1)143-50. doi:10.14336/AD.2017.0306
  35. Mackowiak J, Jones J, Dasa V. A comparison of 4-year total medical care costs, adverse outcomes, and opioid/prescription analgesic use for 3 knee osteoarthritis pain treatments: Intra-articular hyaluronic acid, intra-articular corticosteroids, and knee arthroplasty. Semin Arthritis Rheum. 2020;50(6):1525-34. doi:10.1016/j.semarthrit.2020.01.03
  36. Bioventus LLC. DUROLANE patient motivators: a summary of qualitative marketing research findings. Data on file. January 28, 2006.